Margaret M. FitzPatrick's most recent trade in AN2 Therapeutics Inc was a trade of 8,610 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on May 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AN2 Therapeutics Inc | Margaret M. FitzPatrick | Director | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 28 May 2025 | 8,610 | 8,610 | - | 1.2 | 10,133 | Common Stock |
| AN2 Therapeutics Inc | Margaret M. FitzPatrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 19,111 | 19,111 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Margaret M. FitzPatrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 14,100 | 14,100 | - | - | Stock Option (Right to Buy) | |
| AN2 Therapeutics Inc | Margaret M. FitzPatrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 64,503 | 64,503 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Margaret M. FitzPatrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| AN2 Therapeutics Inc | Margaret M. FitzPatrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 10,362 | 10,362 | - | - | Stock Option (right to buy) | |
| AN2 Therapeutics Inc | Margaret M. FitzPatrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 11,463 | 11,463 | - | - | Stock Option (right to buy) | |
| VistaGen Therapeutics Inc | Margaret M. FitzPatrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Margaret M. FitzPatrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2021 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) |